{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:20:27Z","timestamp":1791231627220,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/2051-5960-1-76","type":"journal-article","created":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T01:25:30Z","timestamp":1384824330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Brains from non-Alzheimer\u2019s individuals containing amyloid deposits accelerate A\u03b2 deposition in vivo"],"prefix":"10.1186","volume":"1","author":[{"given":"Claudia","family":"Duran-Aniotz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Moreno-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping Ping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,18]]},"reference":[{"key":"72_CR1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","volume":"60","author":"LE Hebert","year":"2003","unstructured":"Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA: Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003, 60: 1119\u20131122.","journal-title":"Arch Neurol"},{"issue":"7","key":"72_CR2","first-page":"208","volume":"2011","author":"W Thies","year":"2011","unstructured":"Thies W, Bleiler L: Alzheimer's disease facts and figures. Alzheimers Dement 2011,2011(7):208\u2013244.","journal-title":"Alzheimers Dement"},{"key":"72_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0072-9752(07)01222-5","volume":"89","author":"T Gomez-Isla","year":"2008","unstructured":"Gomez-Isla T, Spires T, de CA, Hyman BT: Neuropathology of Alzheimer's disease. Handb Clin Neurol 2008, 89: 233\u2013243.","journal-title":"Handb Clin Neurol"},{"key":"72_CR4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3233\/JAD-2002-4302","volume":"4","author":"S Estus","year":"2002","unstructured":"Estus S, Borchelt D, Kindy MS, Vassar R: Abeta deposition is essential to AD neuropathology. J Alzheimers Dis 2002, 4: 133\u2013138.","journal-title":"J Alzheimers Dis"},{"key":"72_CR5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.neurobiolaging.2005.04.017","volume":"27","author":"CG Glabe","year":"2006","unstructured":"Glabe CG: Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging 2006, 27: 570\u2013575.","journal-title":"Neurobiol Aging"},{"key":"72_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ: Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 2007, 8: 101\u2013112.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"72_CR7","doi-asserted-by":"publisher","first-page":"a006338","DOI":"10.1101\/cshperspect.a006338","volume":"2","author":"L Mucke","year":"2012","unstructured":"Mucke L, Selkoe DJ: Neurotoxicity of Amyloid beta-Protein: Synaptic and Network Dysfunction. Cold Spring Harb Perspect Med 2012, 2: a006338.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"72_CR8","doi-asserted-by":"publisher","first-page":"46179","DOI":"10.1074\/jbc.M301874200","volume":"278","author":"K Murakami","year":"2003","unstructured":"Murakami K, Irie K, Morimoto A, Ohigashi H, Shindo M, Nagao M, Shimizu T, Shirasawa T: Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease. J Biol Chem 2003, 278: 46179\u201346187.","journal-title":"J Biol Chem"},{"key":"72_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM: Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39: 409\u2013421.","journal-title":"Neuron"},{"key":"72_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","volume":"68","author":"PT Nelson","year":"2009","unstructured":"Nelson PT, Braak H, Markesbery WR: Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol 2009, 68: 1\u201314.","journal-title":"J Neuropathol Exp Neurol"},{"key":"72_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/alzrt121","volume":"4","author":"BD Moore","year":"2012","unstructured":"Moore BD, Chakrabarty P, Levites Y, Kukar TL, Baine AM, Moroni T, Ladd TB, Das P, Dickson DW, Golde TE: Overlapping profiles of Abeta peptides in the Alzheimer's disease and pathological aging brains. Alzheimers Res Ther 2012, 4: 18.","journal-title":"Alzheimers Res Ther"},{"key":"72_CR12","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","volume":"30","author":"JL Price","year":"2009","unstructured":"Price JL, McKeel DW Jr, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, et al.: Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 2009, 30: 1026\u20131036.","journal-title":"Neurobiol Aging"},{"key":"72_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, et al.: Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 2013, 12: 207\u2013216.","journal-title":"Lancet Neurol"},{"key":"72_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/archneur.63.5.665","volume":"63","author":"RC Petersen","year":"2006","unstructured":"Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, Jicha GA, Ivnik RJ, Smith GE, Tangalos EG, et al.: Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 2006, 63: 665\u2013672.","journal-title":"Arch Neurol"},{"key":"72_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/ana.21598","volume":"65","author":"DA Wolk","year":"2009","unstructured":"Wolk DA, Price JC, Saxton JA, Snitz BE, James JA, Lopez OL, Aizenstein HJ, Cohen AD, Weissfeld LA, Mathis CA, et al.: Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol 2009, 65: 557\u2013568.","journal-title":"Ann Neurol"},{"key":"72_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(04)00710-0","volume":"3","author":"B Dubois","year":"2004","unstructured":"Dubois B, Albert ML: Amnestic MCI or prodromal Alzheimer's disease? Lancet Neurol 2004, 3: 246\u2013248.","journal-title":"Lancet Neurol"},{"key":"72_CR17","first-page":"93","volume":"15","author":"RC Petersen","year":"2000","unstructured":"Petersen RC: Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurologia 2000, 15: 93\u2013101.","journal-title":"Neurologia"},{"key":"72_CR18","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1212\/01.WNL.0000152982.47274.9E","volume":"64","author":"DA Bennett","year":"2005","unstructured":"Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS: Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 2005, 64: 834\u2013841.","journal-title":"Neurology"},{"key":"72_CR19","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1056\/NEJMcp0910237","volume":"364","author":"RC Petersen","year":"2011","unstructured":"Petersen RC: Clinical practice. Mild cognitive impairment. N Engl J Med 2011, 364: 2227\u20132234.","journal-title":"N Engl J Med"},{"key":"72_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999, 56: 303\u2013308.","journal-title":"Arch Neurol"},{"key":"72_CR21","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1212\/01.wnl.0000341273.18141.64","volume":"72","author":"D Erten-Lyons","year":"2009","unstructured":"Erten-Lyons D, Woltjer RL, Dodge H, Nixon R, Vorobik R, Calvert JF, Leahy M, Montine T, Kaye J: Factors associated with resistance to dementia despite high Alzheimer disease pathology. Neurology 2009, 72: 354\u2013360.","journal-title":"Neurology"},{"key":"72_CR22","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1523\/JNEUROSCI.20-10-03606.2000","volume":"20","author":"MD Kane","year":"2000","unstructured":"Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, Roher AE, Walker LC: Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J Neurosci 2000, 20: 3606\u20133611.","journal-title":"J Neurosci"},{"key":"72_CR23","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1126\/science.1131864","volume":"313","author":"M Meyer-Luehmann","year":"2006","unstructured":"Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, et al.: Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 2006, 313: 1781\u20131784.","journal-title":"Science"},{"key":"72_CR24","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/mp.2011.120","volume":"17","author":"R Morales","year":"2012","unstructured":"Morales R, Duran-Aniotz C, Castilla J, Estrada LD, Soto C: De novo induction of amyloid-beta deposition in vivo. Mol Psychiatry 2012, 17: 1347\u20131353.","journal-title":"Mol Psychiatry"},{"key":"72_CR25","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1471-4159.2011.07551.x","volume":"120","author":"RF Rosen","year":"2012","unstructured":"Rosen RF, Fritz JJ, Dooyema J, Cintron AF, Hamaguchi T, Lah JJ, LeVine H III, Jucker M, Walker LC: Exogenous seeding of cerebral beta-amyloid deposition in betaAPP-transgenic rats. J Neurochem 2012, 120: 660\u2013666.","journal-title":"J Neurochem"},{"key":"72_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tibs.2006.01.002","volume":"31","author":"C Soto","year":"2006","unstructured":"Soto C, Estrada L, Castilla J: Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem Sci 2006, 31: 150\u2013155.","journal-title":"Trends Biochem Sci"},{"key":"72_CR27","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1126\/science.1222951","volume":"336","author":"SB Prusiner","year":"2012","unstructured":"Prusiner SB: Cell biology. A unifying role for prions in neurodegenerative diseases. Science 2012, 336: 1511\u20131513.","journal-title":"Science"},{"key":"72_CR28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.neuron.2009.12.016","volume":"64","author":"A Aguzzi","year":"2009","unstructured":"Aguzzi A, Rajendran L: The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 2009, 64: 783\u2013790.","journal-title":"Neuron"},{"key":"72_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrm2873","volume":"11","author":"P Brundin","year":"2010","unstructured":"Brundin P, Melki R, Kopito R: Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 2010, 11: 301\u2013307.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"72_CR30","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2012.05.007","volume":"149","author":"C Soto","year":"2012","unstructured":"Soto C: Transmissible proteins: expanding the prion heresy. Cell 2012, 149: 968\u2013977.","journal-title":"Cell"},{"key":"72_CR31","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1126\/science.1194516","volume":"330","author":"YS Eisele","year":"2010","unstructured":"Eisele YS, Obermuller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, Walker LC, Staufenbiel M, Heikenwalder M, Jucker M: Peripherally applied A{beta}-containing inoculates induce cerebral {beta}-amyloidosis. Science 2010, 330: 980\u2013982.","journal-title":"Science"},{"key":"72_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00401-011-0912-1","volume":"123","author":"T Hamaguchi","year":"2012","unstructured":"Hamaguchi T, Eisele YS, Varvel NH, Lamb BT, Walker LC, Jucker M: The presence of Abeta seeds, and not age per se, is critical to the initiation of Abeta deposition in the brain. Acta Neuropathol 2012, 123: 31\u201337.","journal-title":"Acta Neuropathol"},{"key":"72_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, et al.: Mutant presenilins specifically elevate the levels of the 42 residue beta}-amyloid peptide in vivo: evidence for augmentation of a 42-specific {gamma secretase. Hum Mol Genet 2004, 13: 159\u2013170.","journal-title":"Hum Mol Genet"},{"key":"72_CR34","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","volume":"24","author":"M Garcia-Alloza","year":"2006","unstructured":"Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, Frosch MP: Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 2006, 24: 516\u2013524.","journal-title":"Neurobiol Dis"},{"key":"72_CR35","doi-asserted-by":"publisher","first-page":"11025","DOI":"10.1073\/pnas.1206555109","volume":"109","author":"J Stohr","year":"2012","unstructured":"Stohr J, Watts JC, Mensinger ZL, Oehler A, Grillo SK, DeArmond SJ, Prusiner SB, Giles K: Purified and synthetic Alzheimer's amyloid beta (Abeta) prions. Proc Natl Acad Sci USA 2012, 109: 11025\u201311030.","journal-title":"Proc Natl Acad Sci USA"},{"key":"72_CR36","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1212\/WNL.55.8.1075","volume":"55","author":"P Brown","year":"2000","unstructured":"Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, et al.: Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000, 55: 1075\u20131081.","journal-title":"Neurology"},{"key":"72_CR37","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jamaneurol.2013.1933","volume":"70","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Abrams JY, Schonberger LB, Leschek EW, Mills JL, Lee VM, Trojanowski JQ: Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of Cadaver-derived human growth hormone. JAMA Neurol 2013, 70: 462\u2013468.","journal-title":"JAMA Neurol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-1-76.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:22:17Z","timestamp":1630549337000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/2051-5960-1-76"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,18]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["72"],"URL":"https:\/\/doi.org\/10.1186\/2051-5960-1-76","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,18]]},"assertion":[{"value":"30 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"76"}}